冯驭

特聘副教授
邮箱:

个人简介

  冯驭,深圳理工大学细胞与基因技术研究院特聘副教授,曾任华大生命科学研究院粤港澳分院副院长,山西医科大学客座教授,获得深圳市高层次海外人才(C类)、盐田区梧桐凤凰人才(C类)等人才称号。冯驭博士主要从事空间多组学技术研发,并开展肿瘤免疫、自身免疫性疾病的研究。冯驭博士致力于研究免疫紊乱的底层机制,研制可用于重大慢性疾病的精准诊疗手段。近年来以第一作者或通讯作者在Cell/Science Translational Medicine/Nature Communications等杂志发表文章多篇,获得深医专项青年项目支持,并参与多项国家级项目。

学习工作经历

2025.05-2026.03 华大生命科学研究院粤港澳分院副院长

2023.01-2025.04 华大生命科学研究院专项科学家

2020.11-2022.12 华大生命科学研究院,博士后

2016.08-2020.10 香港中文大学,生命医学学院,博士

2012.09-2016.06 武汉大学,生命科学与技术基地班,学士

研究领域

空间组学技术研发,肿瘤免疫,自身免疫疾病,免疫受体,抗体药物研发,蛋白结构,人工智能

学术成就

科研项目

深圳市医学研究专项资金项目,原创项目2026-2028-12, 80万元, 主持。

国家卫生健康委, 科技创新2030-“癌症、心脑血管、呼吸和代谢性疾病防治研究”重大专项, 2025-01 至 2028-12, 800万元, 参与。

国家自然科学基金委员会, 专项项目, 2026-01-01 至 2028-12-31, 270万元, 在研, 参与

近五年文章

1. Xiaojuan Zhan*, Mengye Huang*, Yang Zhang*, Zhong Liu*, Chengwu Liu, Yanying Guo, Yi Liu,Wenwen Zhou, Yixin Yan, Hui Zeng, Yingqi Dong, Xuan Dong, Xiaoyu Chen, Haohang Yang, Rong Ma, Fan Zhu, Xubin Zheng, Xinxing Li, Sen Hou, Zhidong Gao, Jinwen Yin,  Francis Ka-ming Chan, Qin Wu, Senyi Deng, Yin Yao, Shengbao Suo, Chuanyu Liu, Longqi Liu , Xun Xu, Yong Hou, Haoran Tao, Yuliang Dong, Tao Zeng, Young Li, Li Zuo, Hua Wang, Xin Liu, Jingying Zhou#, Zexian Zeng#, Yu Feng#. Uncovering ectopic germinal centers for tumor reactive lymphocyte priming in lung adenocarcinoma using Stereo-XCR-seq. Nat Commun, 3rd review.

2. Haorui Zhang*, Zongxu Zhang*, Peiyu Wang*, Tian Xu, Xiaoyu Chen, Yanping Zhao, Siyu Lin, Wenjie Cai, Pengfei Ren, Ce Luo, Peng Zhang, Yunfeng Wang, Sen Hou, Hu Zeng, Zhidong Gao, Yu Feng#, Deng Pan#, Zexian Zeng#. Cell, Accepted.

3. Xiaojuan Zhan, Yi Liu, Yanying Guo, Wenwen Zhou, Yixin Yan, Hui Zeng, Xuan Dong, Xiaoyu Chen, Rong Ma, Zhong Liu, Fan Zhu, Xubin Zheng, Xinxing Li, Jinwen Yin, Francis Ka-ming Chan, Chuanyu Liu, Longqi Liu, Xun Xu, Yong Hou, Haoran Tao, Yuliang Dong, Tao Zeng, Young Li#, Jingying Zhou#, Zexian Zeng#, Yu Feng# (2025). Single cell resolved spatial immune repertoire unveils spatial heterogeneity of lymphoid aggregates in human immune disorders. bioRxiv, 2025-01. https://doi.org/10.1101/2025.01.16.630222

4. Yu Feng*, Wenjuan Ma*, Yupeng Zang, Yanying Guo, Young Li, Yixuan Zhang, Xuan Dong, Yi Liu, Xiaojuan Zhan, Zhizhong Pan, Mei Luo, Miaoqing Wu, Ao Chen, Da Kang, Gong Chen, Longqi Liu, Jingying Zhou, Rongxin Zhang (2024). Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients. Nature Communications, 15(1), 10259. https://doi.org/10.1038/s41467-024-54710-3

5. Rongxin Zhang*, Yu Feng*, Wenjuan Ma*, Yanying Guo, Mei Luo, Young Li, Yupeng Zang, Xuan Dong, Shixun Lu, Qiang Guo, Qumiao Xu, Huanyi Chen, Yijian Li, Longqi Liu, Ao Chen, Gong Chen, Xun Xu(2023). Spatial transcriptome unveils a discontinuous inflammatory pattern in proficient mismatch repair colorectal adenocarcinoma. Fundamental Research, 3(4), 640-646. https://doi.org/10.1016/j.fmre.2022.01.036

6. Weiqin Yang*, Yu Feng*, Jingying Zhou*, Otto Ka-Wing Cheung, Jianquan Cao, Jing Wang, Wenshu Tang, Yalin Tu, Liangliang Xu, Feng Wu, Zhiwu Tan, Hanyong Sun, Yuan Tian, John Wong, Paul Bo-San Lai, Stephen Lam Chan, Anthony Wing-Hung Chan, Patrick Boon-Ooi Tan, Zhiwei Chen, Joseph Jao-Yiu Sung, Kevin Yuk-Lap Yip, Ka-Fai To, and Alfred Sze-Lok Cheng (2021). A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma. Science translational medicine, 13(588), eaaz6804. https://doi.org/10.1126/scitranslmed.aaz6804

7. Bingying Luo, Fei Teng, Guo Tang, Weixuan Chen, Chi Qu, Xuanzhu Liu, Xin Liu, Xing Liu, Huaqiang Huang, Yu Feng, Xue Zhang, Min Jian, Mei Li, Feng Xi, Guibo Li, Sha Liao, Ao Chen, Xun Xu, Jiajun Zhang. StereoMM: A Graph Fusion Model for Integrating Spatial Transcriptomic Data and Pathological Images. Briefings in Bioinformatics, 2025-03, https://doi.org/10.1093/bib/bbaf210.

8. Da Kang, Shanshan Huang, Yijun Liao, Siyuan Mi, Jingying Zhou, Yu Feng, Riming Huang, Zhen-hai Lu, Z. Z. Pan, Wenjuan Ma, Gong Chen, Jia-Xing Yue, Jingxiu Huang & R. X. Zhang (2024). Vasorin (VASN) overexpression promotes pulmonary metastasis and resistance to adjuvant chemotherapy in patients with locally advanced rectal cancer. Journal of Translational Medicine, 22(1), 742. https://doi.org/10.1186/s12967-024-05473-4

9. Zhewen Xiong, Stephen Lam Chan, Jingying Zhou, Joaquim SL Vong, Tsz Tung Kwong, Xuezhen Zeng, Haoran Wu, Jianquan Cao, Yalin Tu, Yu Feng, Weiqin Yang, Patrick Pak-Chun Wong, Willis Wai-Yiu Si-Tou, Xiaoyu Liu, Jing Wang, Wenshu Tang, Zhixian Liang, Jiahuan Lu, Ka Man Li, Jie-Ting Low, Michael Wing-Yan Chan, Howard HW Leung, Anthony WH Chan, Ka-Fai To, Kevin Yuk-Lap Yip, Yuk Ming Dennis Lo, Joseph Jao-Yiu Sung, Alfred Sze-Lok Cheng (2023). Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma. Gut, 72(9), 1758-1773. https://doi.org/10.1136/gutjnl-2022-328364